IN2014MU01128A - - Google Patents

Download PDF

Info

Publication number
IN2014MU01128A
IN2014MU01128A IN1128MU2014A IN2014MU01128A IN 2014MU01128 A IN2014MU01128 A IN 2014MU01128A IN 1128MU2014 A IN1128MU2014 A IN 1128MU2014A IN 2014MU01128 A IN2014MU01128 A IN 2014MU01128A
Authority
IN
India
Prior art keywords
composition containing
maturation
delaying
diabetes
administering
Prior art date
Application number
Other languages
English (en)
Inventor
Deshpande Dr Jayant
J Shankaranarayanan
Original Assignee
Omniactive Health Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IN1128MU2014 priority Critical patent/IN2014MU01128A/en
Priority to SG11201607996SA priority patent/SG11201607996SA/en
Priority to CN201580017290.3A priority patent/CN106163536A/zh
Priority to AU2015237806A priority patent/AU2015237806A1/en
Priority to EP15717249.5A priority patent/EP3122339A2/fr
Priority to JP2017501531A priority patent/JP2017511380A/ja
Priority to KR1020167030397A priority patent/KR20160140859A/ko
Priority to PCT/IB2015/052248 priority patent/WO2015145389A2/fr
Application filed by Omniactive Health Technologies Ltd filed Critical Omniactive Health Technologies Ltd
Priority to US15/300,210 priority patent/US20170143646A1/en
Priority to CA2943921A priority patent/CA2943921A1/fr
Priority to MX2016012625A priority patent/MX2016012625A/es
Publication of IN2014MU01128A publication Critical patent/IN2014MU01128A/en
Priority to IL248016A priority patent/IL248016A0/en
Priority to PH12016501914A priority patent/PH12016501914A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
IN1128MU2014 2014-03-28 2015-03-26 IN2014MU01128A (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
KR1020167030397A KR20160140859A (ko) 2014-03-28 2015-03-26 당뇨성 안질환에 대한 친지질성 영양소의 효과
CN201580017290.3A CN106163536A (zh) 2014-03-28 2015-03-26 亲脂性营养素对糖尿病性眼病的作用
AU2015237806A AU2015237806A1 (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
EP15717249.5A EP3122339A2 (fr) 2014-03-28 2015-03-26 Effet de nutriments lipophiles sur des maladies des yeux liées au diabète
JP2017501531A JP2017511380A (ja) 2014-03-28 2015-03-26 脂溶性栄養素の糖尿病性眼疾患への効果
IN1128MU2014 IN2014MU01128A (fr) 2014-03-28 2015-03-26
CA2943921A CA2943921A1 (fr) 2014-03-28 2015-03-26 Effet de nutriments lipophiles sur des maladies des yeux liees au diabete
PCT/IB2015/052248 WO2015145389A2 (fr) 2014-03-28 2015-03-26 Effet de nutriments lipophiles sur des maladies des yeux liées au diabète
US15/300,210 US20170143646A1 (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
SG11201607996SA SG11201607996SA (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
MX2016012625A MX2016012625A (es) 2014-03-28 2015-03-26 Efecto de nutrientes lipofilicos en enfermedades de ojo diabetico.
IL248016A IL248016A0 (en) 2014-03-28 2016-09-25 Effect of lipophilic nutrients on diabetic eye diseases
PH12016501914A PH12016501914A1 (en) 2014-03-28 2016-09-27 Effect of lipophilic nutrients on diabetic eye diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1128MU2014 IN2014MU01128A (fr) 2014-03-28 2015-03-26

Publications (1)

Publication Number Publication Date
IN2014MU01128A true IN2014MU01128A (fr) 2015-10-02

Family

ID=54196517

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1128MU2014 IN2014MU01128A (fr) 2014-03-28 2015-03-26

Country Status (13)

Country Link
US (1) US20170143646A1 (fr)
EP (1) EP3122339A2 (fr)
JP (1) JP2017511380A (fr)
KR (1) KR20160140859A (fr)
CN (1) CN106163536A (fr)
AU (1) AU2015237806A1 (fr)
CA (1) CA2943921A1 (fr)
IL (1) IL248016A0 (fr)
IN (1) IN2014MU01128A (fr)
MX (1) MX2016012625A (fr)
PH (1) PH12016501914A1 (fr)
SG (1) SG11201607996SA (fr)
WO (1) WO2015145389A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017137294A (ja) * 2016-01-29 2017-08-10 静岡県公立大学法人 ショウガ科植物抽出物送達用組成物
US20190125694A1 (en) * 2016-04-16 2019-05-02 Omniactive Health Technologies Limited Method for treatment of visual stress conditions and compositions used therein
US20180168182A1 (en) * 2016-12-21 2018-06-21 Muhammed Majeed Chewable compositions containing curcuminoids and their method of preparation
WO2019050542A1 (fr) * 2017-09-11 2019-03-14 Verdure Sciences Procédés et compositions pour le traitement de maladies rétiniennes, neurologiques et d'autres maladies associées
CN108421020A (zh) * 2018-05-29 2018-08-21 李玉梅 一种用于治疗糖尿病视网膜病的生姜提取物及其制备方法和用途
US11141386B1 (en) 2018-12-28 2021-10-12 QH Holdings (Oregon), Inc. Eye health supplement with curcumin
US11135179B1 (en) 2018-12-28 2021-10-05 QH Holdings (Oregon), Inc. Eye health supplement
US20220193008A1 (en) * 2019-04-26 2022-06-23 Shankaranarayanan JEYAKODI Bioaccessibile compositions of lipophilic compounds and process thereof
EP3967148A4 (fr) * 2019-05-06 2022-12-21 Shenzhen Linpingxijing Vision Technology Co., Ltd Bonbon à base de plantes nourrissant pour l' il et améliorant la vue contenant des nutriments pour cristallins humains et cellules photosensibles rétiniennes
KR20220082812A (ko) * 2019-10-15 2022-06-17 옴니액티브 헬스 테크놀로지스 리미티드 루테인 및 제아잔틴을 포함하는 생체이용가능성이 증강된 크산토필 조성물
CA3156787A1 (fr) * 2019-11-15 2021-05-20 Muralidhara Padigaru Composition nutritive associee a la fonction visuelle
CN112006282A (zh) * 2020-09-04 2020-12-01 北京瑞济善健康科技有限公司 一种修复糖尿病并发症的组合物及其制备方法与应用
DE102022122731A1 (de) * 2022-09-07 2024-03-07 Ruma Gmbh Metabolisierbare Kontroll-Marker für die endogene Markierung von Urin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
US6737535B2 (en) 2002-06-05 2004-05-18 Kancor Flavours And Extracts Limited Trans-lutein enriched xanthophyll ester concentrate and a process for its preparation
US6743953B2 (en) 2002-08-26 2004-06-01 Kancor Flavours & Extracts Ltd. Process for the preparation of xanthophyll crystals
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
EP2152252A4 (fr) * 2006-11-13 2010-06-02 Univ Columbia Inhibiteurs de protéasome sélectifs pour traiter le diabète
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health
EP2326338B1 (fr) 2008-09-22 2015-08-05 Innoveda Biological Solutions (P) Ltd. Formulation à base de plantes pour la prévention et le traitement du diabète et de complications associées
US20120114637A1 (en) 2009-05-04 2012-05-10 Santen Pharmaceutical Co., Ltd. Mtor pathway inhibitors for treating ocular disorders
EP2473065B1 (fr) * 2009-09-02 2016-04-13 OmniActive Health Technologies Ltd. Composition de xanthophiles comprenant des pigments de la macula et procede de preparation
US20110300246A1 (en) * 2010-06-03 2011-12-08 Qinheng Huang Herbal Extracts for Treatment of Diabetic Complications and Oxidative Stress
EP2433640B1 (fr) 2010-09-24 2020-01-15 OmniVision GmbH Composition comprenant de la superoxyde dismutase, de la lutéine et de la zéaxanthine
CN102178925A (zh) 2011-04-25 2011-09-14 崔晓廷 新型视力保护剂叶黄素眼用制剂
CN102225087A (zh) * 2011-06-09 2011-10-26 雷爱林 一种强效护眼的叶黄素复方制剂
HK1211836A1 (en) * 2013-03-28 2016-06-03 Omniactive Health Technologies Limited Neuroprotective effect of carotenoids in brain
CN103238902B (zh) * 2013-05-23 2014-12-03 云南瑞宝生物科技有限公司 一种果珍及其制备方法

Also Published As

Publication number Publication date
SG11201607996SA (en) 2016-11-29
AU2015237806A1 (en) 2016-10-20
JP2017511380A (ja) 2017-04-20
PH12016501914A1 (en) 2017-01-09
CA2943921A1 (fr) 2015-10-01
WO2015145389A3 (fr) 2015-11-26
WO2015145389A2 (fr) 2015-10-01
IL248016A0 (en) 2016-11-30
MX2016012625A (es) 2017-01-09
KR20160140859A (ko) 2016-12-07
EP3122339A2 (fr) 2017-02-01
US20170143646A1 (en) 2017-05-25
CN106163536A (zh) 2016-11-23

Similar Documents

Publication Publication Date Title
IN2014MU01128A (fr)
MX2015011966A (es) Compuestos de resorcinol para uso dermatologico.
PH12014500630A1 (en) An efficient process for the preparation of lycopene containing oleoresin and lycopene crystals for human consumption
AR103260A1 (es) Modulación inmunitaria
PH12015502238A1 (en) Neuroprotective effect of carotenoids in brain
HK1246097A1 (zh) 含有壳多糖和可消化蛋白的组合物
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
BR112017013004A2 (pt) produto frito obtido a partir de uma composição para um produto frito, uso de uma farinha de microalgas como substituta da gordura e método de preparação de um produto frito
CL2017000475A1 (es) Composición para formulación cosmética que consiste en una mezcla de hasta 3 componentes seleccionados de manteca de murumuru, manteca de ucuuba, aceite de nuez de brasil, aceite de maracuyá, manteca de copoazú, aceite de acai y aceite de andiroba y/o ésteres de los mismos; producto cosmético.
EP3197857A4 (fr) Composition d'acide gras et procédé d'enrichissement de produits nutritionnels en acides gras
MX2014003539A (es) Harinas termicamente inhibidas para mejorar la eficiencia de la esterilizacion en autoclave.
WO2016080796A3 (fr) Composition pharmaceutique contenant un composé sesquiterpénique et utilisable en vue de la prévention ou du traitement de maladies à médiation par stat3, et son utilisation
BR112017006779A2 (pt) composição farmacêutica oral de baixa dose seu processo de preparação e método de tratamento
MX2017002231A (es) Composicion de grasa comestible.
EP3185695A4 (fr) Préparation de produits de protéines de soja ("s810")
CR20150478A (es) Método para el tratamiento y control de enfermedades de postrecolección de frutas y hortalizas y composiciones que comprenden extractos naturales y formulaciones fitofortificantes y/o fungicidas para aplicar en dicho método.
NZ713235A (en) Product and method for improving bioavailability of therapeutic compounds
PH12017500203B1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair
EP3220933A4 (fr) Procédé pour augmenter les teneurs en acides gras oméga-3 dans des produits bovins et par administration d'un régime alimentaire à base d'herbe et d'algue
BR112017003066A2 (pt) composição de bebida contendo ginseng em pó e método para sua preparação
PH12017500740A1 (en) Nutritional supplements containing a peptide component and uses thereof
CO2018014231A2 (es) Método para el procesamiento de material vegetal
WO2019039936A8 (fr) Composition comprenant une xantophylle et un acide gras oméga-3 et son procédé d'utilisation
BR112018008964A2 (pt) método para induzir saciedade
CL2016002168A1 (es) Producto comestible que disminuye el colesterol en suero